ZOMIG is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Impax Specialty Pharma. The primary component is Zolmitriptan.
| Product ID | 64896-672_51dce449-5220-4582-ba49-b10580ec5009 |
| NDC | 64896-672 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ZOMIG |
| Generic Name | Zolmitriptan |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2012-04-02 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020768 |
| Labeler Name | Impax Specialty Pharma |
| Substance Name | ZOLMITRIPTAN |
| Active Ingredient Strength | 5 mg/1 |
| Pharm Classes | Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2012-04-02 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020768 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2012-04-02 |
| Marketing Category | NDA |
| Application Number | NDA020768 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-04-02 |
| Ingredient | Strength |
|---|---|
| ZOLMITRIPTAN | 5 mg/1 |
| SPL SET ID: | df93b636-103f-4fb5-26b6-50f639e29b1d |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 21695-955 | ZOMIG | Zolmitriptan |
| 68258-7103 | ZOMIG | ZOMIG |
| 64896-682 | ZOMIG | ZOMIG |
| 64896-672 | ZOMIG | ZOMIG |
| 64896-681 | ZOMIG | ZOMIG |
| 64896-671 | ZOMIG | ZOMIG |
| 0115-0671 | Zolmitriptan | Zolmitriptan |
| 0115-0672 | Zolmitriptan | Zolmitriptan |
| 16571-803 | Zolmitriptan | Zolmitriptan |
| 16571-804 | Zolmitriptan | Zolmitriptan |
| 27241-021 | Zolmitriptan | Zolmitriptan |
| 27241-022 | Zolmitriptan | Zolmitriptan |
| 31722-458 | ZOLMITRIPTAN | ZOLMITRIPTAN |
| 31722-459 | ZOLMITRIPTAN | ZOLMITRIPTAN |
| 33342-112 | Zolmitriptan | Zolmitriptan |
| 33342-113 | Zolmitriptan | Zolmitriptan |
| 33342-139 | Zolmitriptan | Zolmitriptan |
| 33342-140 | Zolmitriptan | Zolmitriptan |
| 45802-711 | zolmitriptan | zolmitriptan |
| 46708-181 | Zolmitriptan | Zolmitriptan |
| 46708-182 | Zolmitriptan | Zolmitriptan |
| 46708-462 | Zolmitriptan | Zolmitriptan |
| 46708-463 | Zolmitriptan | Zolmitriptan |
| 50742-625 | Zolmitriptan | Zolmitriptan |
| 50742-626 | Zolmitriptan | Zolmitriptan |
| 55700-943 | Zolmitriptan | Zolmitriptan |
| 55700-944 | Zolmitriptan | Zolmitriptan |
| 55801-322 | Zolmitriptan | Zolmitriptan |
| 55801-323 | Zolmitriptan | Zolmitriptan |
| 59746-432 | Zolmitriptan | Zolmitriptan |
| 59746-433 | Zolmitriptan | Zolmitriptan |
| 59746-461 | Zolmitriptan OD | Zolmitriptan |
| 59746-462 | Zolmitriptan OD | Zolmitriptan |
| 0115-0691 | Zolmitriptan Orally Disintegrating | Zolmitriptan |
| 0115-0692 | Zolmitriptan Orally Disintegrating | Zolmitriptan |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ZOMIG 74719034 2175295 Live/Registered |
Wellcome Foundation Limited, The 1995-08-22 |